Key takeaways
Lantus (insulin glargine) and Semglee (insulin glargine-yfgn) are both long-acting insulins used to manage blood sugar levels in people with Type 1 and Type 2 diabetes. They are similar in that they contain the same active ingredient, are both injected under the skin once daily, and help control blood sugar levels throughout the day. However, there are some differences between the two medications. Semglee is an interchangeable biosimilar to Lantus, meaning it can be substituted for Lantus without needing approval from your prescriber. This makes Semglee a potentially lower-cost alternative. Both medications come in vials and prefilled pens. The side effects and risks, such as low blood sugar and weight gain, are similar for both medications.
